Delayed quote
|
Last quote
04/18/2024 -
20:00:00
|
Bid
04/19/2024 -
04:05:17
|
Bid Volume |
Ask
- -
-
|
Ask Volume |
|---|---|---|---|---|
|
62.21
-0.52
(
-0.83% )
|
25.51
|
100 |
-
|
- |
Analysis date: 16.04.2024
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 26.03.2024.
Interest
Very weak
Very weak
Very weak interest since 22.03.2024.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 22.03.2024 at a price of 71.50.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, at its current price the stock is moderately overvalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 19.03.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
-9.05%
-9.05%
The four week relative underperformance versus SP500 is 9.05%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 26.03.2024.
Bear Market Factor
High
High
On average, the stock has a tendency to amplify the drops in the index by 0.93%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.62%.
Mkt Cap in $bn
10.30
10.30
With a market capitalization >$8bn, BIO-TECHNE is considered a large-cap stock.
G/PE Ratio
0.74
0.74
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
27.48
27.48
The estimated PE is for the year 2026.
LT Growth
19.87%
19.87%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.50%
0.50%
The twelve month estimated dividend yield represents 13.74% of earnings forecasts.
Beta
136
136
For 1% of index variation, the stock varies on average by 1.36%.
Correlation
0.48
0.48
47.64% of stock movements are explained by index variations.
Value at Risk
15.37
15.37
The value at risk is estimated at USD 15.37. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004